Feber, A.
930  Ergebnisse:
Personensuche X
?
3

O082 Patient derived renal cell carcinoma tumouroids for pe..:

Bokea, K ; Azimi, T ; Stamati, K...
British Journal of Surgery.  109 (2022)  Supplement_4 - p. , 2022
 
?
 
?
 
?
7

Mix methods approach to determine patients' perspectives on..:

Tan, W.S. ; Teo, C.H. ; Chan, D....
European Urology Supplements.  18 (2019)  1 - p. e303 , 2019
 
?
8

Development and external validation of the haematuria cance..:

Tan, W.S. ; Ahmad, A. ; Feber, A....
European Urology Supplements.  18 (2019)  1 - p. e247-e249 , 2019
 
?
9

Development and validation of a haematuria cancer risk scor..:

Tan, W. S. ; Ahmad, A. ; Feber, A....
Journal of Internal Medicine.  285 (2019)  4 - p. 436-445 , 2019
 
?
10

12 month results of CALIBER: A phase II randomised feasibil..:

Mostafid, H. ; Porta, N. ; Cresswell, J....
European Urology Supplements.  18 (2019)  1 - p. e762-e763 , 2019
 
?
11

BAP1 protein loss in squamous cell carcinoma of the penis i..:

Alnajjar, H.M. ; Alrifai, D. ; Kolluri, K....
European Urology Supplements.  17 (2018)  2 - p. e43-e44 , 2018
 
?
12

Can ultrasound renal tract replace CT intravenous urogram i..:

Tan, W.S. ; Feber, A. ; Sarpong, R....
European Urology Supplements.  17 (2018)  2 - p. e1294 , 2018
 
?
13

Using plasma cell-free DNA mutations to monitor patients fo..:

Khetrapal, P. ; Dong, L. ; Wong, Y.N.S....
European Urology Supplements.  17 (2018)  2 - p. e1527 , 2018
 
?
14

What is the role of urinary cytology as part of haematuria ..:

Tan, W.S. ; Feber, A. ; Sarpong, R....
European Urology Supplements.  17 (2018)  2 - p. e1426 , 2018
 
?
15

Results of CALIBER: A phase II randomised feasibility trial..:

Mostafid, H. ; Cresswell, J. ; Griffiths, T....
European Urology Supplements.  17 (2018)  2 - p. e1062-e1063 , 2018
 
1-15